SEC Company Response from INNOVATE Corp. (VATE) (CIK 0001006837) (VATE) — Mar 27, 2020
INNOVATE Corp. (VATE) (CIK 0001006837)
Date: March 27, 2020 · CIK: 0001006837 · Accession: 0001104659-20-039630
AI Filing Summary & Sentiment
Referenced dates: March 25, 2020
Show Raw Text
CORRESP
1
filename1.htm
Skadden, Arps, Slate, Meagher & Flom llp
ONE MANHATTAN WEST
FIRM/AFFILIATE OFFICES
New York 10001-8602
__________
________
BOSTON
CHICAGO
TEL: (212) 735-3000
HOUSTON
FAX: (212) 735-2000
LOS ANGELES
www.skadden.com
PALO ALTO
DIRECT DIAL
WASHINGTON, D.C.
917-239-5456
WILMINGTON
DIRECT FAX
__________
917-777-2116
BEIJING
EMAIL ADDRESS
BRUSSELS
RICHARD.GROSSMAN@SKADDEN.COM
FRANKFURT
HONG KONG
LONDON
MOSCOW
MUNICH
March 27, 2020
PARIS
SÃO PAULO
SEOUL
SHANGHAI
SINGAPORE
TOKYO
TORONTO
VIA EDGAR TRANSMISSION AND EMAIL
Perry J. Hindin
Special Counsel, Office of Mergers and Acquisitions
Division of Corporation Finance
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
RE: HC2 Holdings, Inc.
Preliminary Consent Revocation Statement on Schedule
14A
Filed on March 20, 2020 by HC2 Holdings,
Inc.
File No. 1-35210
Dear Mr. Hindin:
We
are writing on behalf of our client, HC2 Holdings, Inc., a Delaware corporation (“HC2” or the “Company”),
in response to the letter from the staff of the Office of Mergers and Acquisitions in the Division of Corporation Finance (the
“Staff”) of the Securities and Exchange Commission, dated March 25, 2020 (the “Comment Letter”), relating
to the above-referenced preliminary consent revocation statement on Schedule 14A (the “Preliminary Consent Revocation Statement”).
Set
forth below are HC2’s responses to the comments raised in the Comment Letter. For the convenience of the Staff, each comment
from the Comment Letter is reprinted in bold and is followed by HC2’s response.
Perry J. Hindin
March 27, 2020
Page 2
Preliminary Consent Revocation Statement
Letter to Stockholders
1. Disclosure indicates that “Percy Rockdale has no duty to act in the best interest
of the Company’s stockholders…” With a view towards disclosure, please advise whether any stockholder has a
duty to act in the best interest of stockholders, including when selecting potential nominees to serve on the Board, and what Percy
Rockdale could affirmatively do in its capacity as a stockholder in order to be considered by the Company as acting in the best
interest of the Company’s stockholders. With respect to the reference regarding Percy Rockdale’s duty in selecting
potential nominees to serve on the Board, it is our understanding that notwithstanding Percy Rockdale’s interests, any nominees
elected to the Board would have a state law fiduciary duty to act in the best interest of all stockholders.
Response:
In response to the Staff’s comment, pages i and iii of the Preliminary Consent Revocation Statement have been revised as
follows, to clarify that Percy Rockdale, as a stockholder of the Company, does not have a duty to act in the best interest
of the Company’s stockholders, although if Percy Rockdale’s nominees are elected to the Board, such nominees
would then have a state law fiduciary duty to act in the best interest of all stockholders:
“As
a stockholder of the Company, Percy Rockdale does not have a fiduciary duty to act in the best interests of the Company’s
stockholders (including when selecting potential nominees to serve on your Board, who also do not, and will not, have any such
duty, unless elected to the Board).”
What Happens if the Percy
Rockdale Proposals Pass? page 2
2. Disclosure in the answer to this question indicates that “[t]he Board intends, if
less than all of the members of the Board are removed, to appoint the candidates receiving the most votes, assuming that such candidate(s)
received a majority of the Company Securities entitled to vote, although there can be no assurance that the Board will do so.”
Please revise to disclose the reasons why and circumstances pursuant to which the Board would not do so. Also disclose the potential
consequences, if any, of the Board not doing so.
Response:
In response to the Staff’s comment, pages 2 and 5 of the Preliminary Consent Revocation Statement have been revised to:
(i) include an additional reference to Sections 3 and 4 of Article II of the Company’s Fourth Amended and Restated
By-Laws, which outline the procedures (and the Board’s discretion) to fill vacancies in the Board and (ii) disclose
additional reasons and circumstances to be considered by the Board in exercising its discretion not to fill certain
vacancies, including, among others: (a) potential regulatory issues triggered by a change in composition of the Board, (b)
the qualifications, relevant experience and skillsets of the nominees receiving the most votes and (c) the level of
stockholder support received for each candidate. The disclosure has been revised by including the following
language:
Perry J. Hindin
March 27, 2020
Page 3
“The
Board, in exercising its discretion to fill vacancies in accordance with Sections 3 and 4 of Article II of the By-Laws, may consider
certain reasons and circumstances, including, among others: (i) potential regulatory issues triggered by a change in composition
of the Board (including certain potential issues with the Texas Department of Insurance), (ii) the qualifications, relevant experience
and skillsets of the nominees receiving the most votes, including in relation to the directors on the Board who were not removed
from office, and (iii) the level of stockholder support received for each candidate.”
Reasons to Reject the
Percy Rockdale Proposals, page 6
3. Provide support for the statement that Percy Rockdale is conducting a “value-destructive”
consent solicitation campaign.
Response:
In response to the Staff’s comment, page 6 of the Preliminary Consent Revocation Statement has been revised to remove references
to the “value-destructive” nature of Percy Rockdale’s consent solicitation campaign.
Security Ownership of
Certain Beneficial Owners and Management, page 21
4. Refer to the beneficial ownership table on page 22. Please advise us of the impact, if
any, on the number of shares of common stock beneficially owned by Mr. Falcone disclosed in this table resulting from the order
and judgment dated October 3, 2019 by the Supreme Court of the State of New York, extending to and including December 31, 2020
the effectiveness of an execution and levy served by the sheriff of the city of New York on the Company on May 10, 2019, with respect
to “all property not capable of delivery in the possession of the Company in which judgment debtor Philip Falcone is believed
or known to have an interest.”
Response:
As directed by Item 6 of Schedule 14A, the Company prepared the beneficial ownership table pursuant to Item 403 of Regulation S-K,
including Instructions 2 and 3 to said Item. Accordingly, in preparing the beneficial ownership table the Company considered Mr.
Falcone’s February 14, 2020 disclosure in Amendment No. 25 (the “Schedule 13D/A”) to the Schedule 13D originally
filed by Mr. Falcone on January 7, 2014, together with such other relevant information as was known by the Company. The Company
does not know or have reason to believe that the matters referred to in the Staff’s comment cause such information regarding
Mr. Falcone’s beneficial ownership to be incomplete or inaccurate. Of Mr. Falcone’s shares of Common Stock, 298,461
shares of Common Stock are now in the custody of the sheriff of the City of New York, but the Company believes that such shares
are still beneficially owned by Mr. Falcone. The beneficial ownership table does account for certain other changes in Mr. Falcone’s
beneficial ownership subsequent to the filing of the Schedule 13D/A.
Certain Potential Adverse
Consequences…, page 49
5. Refer to the first sentence of the second paragraph. Please revise to explain why the Company
may be required, as opposed to shall be required, to make an offer to redeem the Preferred Stock upon the occurrence of the events
described in this sentence. In addition, disclose the potential consequences resulting from the Company not having sufficient proceeds
or the financing available to fund the offer to redeem the Preferred Stock.
Perry J. Hindin
March 27, 2020
Page 4
Response:
In response to the Staff’s comment, page 49 of the Preliminary Consent Revocation Statement has been revised as follows,
to clarify that the Company shall be required to redeem the Preferred Stock, unless a waiver from the majority of holders
of the Preferred Stock is obtained:
“[T]he
Company shall be required, unless a waiver is obtained from a majority of holders of the Preferred Stock, to make an offer to
redeem the Preferred Stock at a price per share of Preferred Stock…”
Further,
in response to the Staff’s comment, page 49 of the Preliminary Consent Revocation Statement has been revised to include the
following language to disclose the potential consequences resulting from the Company not having sufficient proceeds or the financing
available to fund the offer to redeem the Preferred Stock:
“Pursuant
to the Certificates of Designation, if the Company does not have sufficient legally available funds to redeem the Preferred Stock,
the Company may be required to pay the portion of the Redemption Price (as defined in the Certificates of Designation) for which
the Company does not have cash legally available out of the remaining assets of the Company legally available (valued at the fair
market value of such assets on the date of payment, as reasonably determined in good faith by the Board). In addition, if the Company
fails to redeem the Preferred Stock in accordance with the terms of the Certificates of Designation, the holders of the Preferred
Stock could obtain a judgment against the Company, and the Company may not have the proceeds or financing available to satisfy
such judgment.”
Proxy Card
6. Please confirm the actual proxy card furnished to stockholders will include the referenced
space in Proposals 2 and 3 to write the name of each person for whom the stockholder does not wish to revoke such stockholder’s
consent.
Response:
In response to the Staff’s comment, the actual proxy card furnished to stockholders will include the referenced space in
Proposals 2 and 3 to write the name of each person for whom the stockholder does not wish to revoke such stockholder’s consent.
Should
you have any questions relating to the foregoing matters or wish to discuss further any of the responses above, please contact
me at (917) 239-5456.
Very truly yours,
/s/ Richard J. Grossman
Richard J. Grossman
Perry J. Hindin
March 27, 2020
Page 5
Enclosure
cc: Joseph A. Ferraro
Chief Legal Officer and Corporate Secretary
HC2 Holdings, Inc.
Todd E. Freed
Skadden, Arps, Slate, Meagher & Flom
LLP